Subjects to be considered in partial replicate BE study [RSABE / ABEL]

posted by cher0424 – China, 2015-01-08 10:51 (3682 d 02:32 ago) – Posting: # 14249
Views: 29,389

Dear Detlew

Sorry to ask again, but I can't see any contradiction between point 1 and 3.
And to point 1 and 2, subjects who complete at least two periods with at least one test and one reference treatment of the study will be included in the pharmacokinetic and statistical analysis,so then can be considered for Bioequivalence.

Is it causal relationship between 1 and 2??
And do you know any literature about statistical analysis of partial replicate BE study?

Complete thread:

UA Flag
Activity
 Admin contact
23,376 posts in 4,912 threads, 1,666 registered users;
198 visitors (0 registered, 198 guests [including 8 identified bots]).
Forum time: 13:23 CET (Europe/Vienna)

Operational hectic replaces
intellectual calms.    Alexander Huiskes

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5